Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891615092> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2891615092 abstract "This study was conducted to evaluate the safety and efficacy of fixed-dose combination (FDC) of rosuvastatin and choline fenofibrate in comparison to rosuvastatin and fenofibrate FDC among Indian patients of mixed dyslipidemia. This would be a first study evaluating FDC of rosuvastatin and choline fenofibrate in Indian population.A multicenter, open-label, randomized, active controlled, comparative, parallel-design study was conducted at 12 centers spread all across India. Mixed dyslipidemic patients aged 18-70 years were randomized to FDC of rosuvastatin 10 mg and choline fenofibrate 135 mg (RCF group) and FDC of rosuvastatin 10 mg and fenofibrate 160 mg (RF group) once daily for approximately 180 days. The primary endpoint of study was percentage change in serum triglyceride level at the end of study from baseline.Of 290 patients screened, 240 patients were enrolled in this study (120 patients in each group). At the end of 180 days, there was a significant reduction in triglyceride level in both the groups (-37.7% in RCF group and -37.8% reduction in RF group; P < 0.0001 for both); however, the difference between both the groups was not statistically significant (P = 0.94). Similarly, there was significant increase (P < 0.0001 for both) in high-density lipoprotein cholesterol (HDL-C) in both groups (+17.8% in RCF group and +14.9% in rosuvastatin fenofibrate RF group). Low-density lipoprotein cholesterol (LDL-C), very low-LDL (VLDL-C), and total cholesterol were also reduced significantly in both groups (P < 0.0001). However, the difference between two groups for increase in HDL-C and decrease in LDL-C, VLDL-C, and total cholesterol was not significant. Both the treatments were safe and well tolerated.Overall, FDC of rosuvastatin and choline fenofibrate is as safe and effective as rosuvastatin and fenofibrate combination in Indian patients with mixed dyslipidemia with added advantage improved patient compliance as it can be taken irrespective of intake of food." @default.
- W2891615092 created "2018-09-27" @default.
- W2891615092 creator A5004515355 @default.
- W2891615092 creator A5035910013 @default.
- W2891615092 creator A5070408233 @default.
- W2891615092 creator A5070489582 @default.
- W2891615092 date "2018-01-01" @default.
- W2891615092 modified "2023-09-27" @default.
- W2891615092 title "Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population" @default.
- W2891615092 cites W172350394 @default.
- W2891615092 cites W1988048988 @default.
- W2891615092 cites W2019071303 @default.
- W2891615092 cites W2019277539 @default.
- W2891615092 cites W2093380242 @default.
- W2891615092 cites W2106340207 @default.
- W2891615092 cites W2171197951 @default.
- W2891615092 cites W2238147233 @default.
- W2891615092 cites W4236673002 @default.
- W2891615092 doi "https://doi.org/10.4103/ijem.ijem_321_16" @default.
- W2891615092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6166558" @default.
- W2891615092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30294571" @default.
- W2891615092 hasPublicationYear "2018" @default.
- W2891615092 type Work @default.
- W2891615092 sameAs 2891615092 @default.
- W2891615092 citedByCount "1" @default.
- W2891615092 countsByYear W28916150922021 @default.
- W2891615092 crossrefType "journal-article" @default.
- W2891615092 hasAuthorship W2891615092A5004515355 @default.
- W2891615092 hasAuthorship W2891615092A5035910013 @default.
- W2891615092 hasAuthorship W2891615092A5070408233 @default.
- W2891615092 hasAuthorship W2891615092A5070489582 @default.
- W2891615092 hasBestOaLocation W28916150921 @default.
- W2891615092 hasConcept C126322002 @default.
- W2891615092 hasConcept C126894567 @default.
- W2891615092 hasConcept C168563851 @default.
- W2891615092 hasConcept C2776623344 @default.
- W2891615092 hasConcept C2778096610 @default.
- W2891615092 hasConcept C2778110834 @default.
- W2891615092 hasConcept C2780499067 @default.
- W2891615092 hasConcept C2908737378 @default.
- W2891615092 hasConcept C511355011 @default.
- W2891615092 hasConcept C71924100 @default.
- W2891615092 hasConcept C90924648 @default.
- W2891615092 hasConcept C98274493 @default.
- W2891615092 hasConceptScore W2891615092C126322002 @default.
- W2891615092 hasConceptScore W2891615092C126894567 @default.
- W2891615092 hasConceptScore W2891615092C168563851 @default.
- W2891615092 hasConceptScore W2891615092C2776623344 @default.
- W2891615092 hasConceptScore W2891615092C2778096610 @default.
- W2891615092 hasConceptScore W2891615092C2778110834 @default.
- W2891615092 hasConceptScore W2891615092C2780499067 @default.
- W2891615092 hasConceptScore W2891615092C2908737378 @default.
- W2891615092 hasConceptScore W2891615092C511355011 @default.
- W2891615092 hasConceptScore W2891615092C71924100 @default.
- W2891615092 hasConceptScore W2891615092C90924648 @default.
- W2891615092 hasConceptScore W2891615092C98274493 @default.
- W2891615092 hasLocation W28916150921 @default.
- W2891615092 hasLocation W28916150922 @default.
- W2891615092 hasLocation W28916150923 @default.
- W2891615092 hasLocation W28916150924 @default.
- W2891615092 hasOpenAccess W2891615092 @default.
- W2891615092 hasPrimaryLocation W28916150921 @default.
- W2891615092 hasRelatedWork W2006203446 @default.
- W2891615092 hasRelatedWork W2019487945 @default.
- W2891615092 hasRelatedWork W2028902898 @default.
- W2891615092 hasRelatedWork W2076224130 @default.
- W2891615092 hasRelatedWork W2147236743 @default.
- W2891615092 hasRelatedWork W2238147233 @default.
- W2891615092 hasRelatedWork W2351583811 @default.
- W2891615092 hasRelatedWork W2371994342 @default.
- W2891615092 hasRelatedWork W2385956122 @default.
- W2891615092 hasRelatedWork W2392307505 @default.
- W2891615092 hasRelatedWork W2514505698 @default.
- W2891615092 hasRelatedWork W2567218979 @default.
- W2891615092 hasRelatedWork W2743233925 @default.
- W2891615092 hasRelatedWork W2746257371 @default.
- W2891615092 hasRelatedWork W2791568876 @default.
- W2891615092 hasRelatedWork W2799444118 @default.
- W2891615092 hasRelatedWork W3003876393 @default.
- W2891615092 hasRelatedWork W3195996039 @default.
- W2891615092 hasRelatedWork W2182700517 @default.
- W2891615092 hasRelatedWork W2550230000 @default.
- W2891615092 isParatext "false" @default.
- W2891615092 isRetracted "false" @default.
- W2891615092 magId "2891615092" @default.
- W2891615092 workType "article" @default.